# Bolt Biotherapeutics (BOLT) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/BOLT
## Company Profile
- Ticker: BOLT
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 3.95 USD
- Market cap: 9819207.370000001 USD
- Last updated: 2026-08-05
## Business Overview
### Immune-Stimulating Antibody Conjugates
Bolt Biotherapeutics develops Boltbody immune-stimulating antibody conjugates that combine tumor targeting with activation of innate and adaptive immunity.
### BDC-4182
BDC-4182 targets claudin 18.2 and is being evaluated in gastric, gastroesophageal junction, pancreatic, and other solid tumors.
### Mechanistic Positioning
The program is designed to combine antibody-drug conjugate-like precision with durable immune activation associated with T-cell-engaging therapies.
## Why The Stock Is Moving

As of Aug 5, 2026, BOLT was little changed and closed at $3.95. No new same-company headline was identified in the current news window.

## Future Catalysts

- Initial Phase 1/2 BDC-4182 clinical data in gastric and gastroesophageal cancers are expected in the third quarter of 2026.

## Recent News
- 2026-05-12 20:05 EST — [Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/BOLT/bolt-biotherapeutics-reports-first-quarter-2026-financial-results-and-provides-b-b5fec9e5) — Source: Bolt Biotherapeutics
- 2026-03-12 20:05 EST — [Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/BOLT/bolt-biotherapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-e284d9b8) — Source: Bolt Biotherapeutics
- 2026-02-24 13:00 EST — [Bolt Biotherapeutics to Participate in Upcoming March Conferences](https://biopharmsignal.com/news/BOLT/bolt-biotherapeutics-to-participate-in-upcoming-march-conferences-d58ae5f3) — Source: Bolt Biotherapeutics
- 2025-11-12 21:05 EST — [Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/BOLT/bolt-biotherapeutics-reports-third-quarter-2025-financial-results-and-provides-b-237a81ff) — Source: Bolt Biotherapeutics
- 2025-10-01 20:05 EST — [Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027](https://biopharmsignal.com/news/BOLT/bolt-biotherapeutics-provides-update-on-bdc-4182-and-extends-cash-runway-into-20-8bbaa910) — Source: Bolt Biotherapeutics